Medfin Pharma Services Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 04-01-2025
- Paid Up Capital ₹ 2.00 M
as on 04-01-2025
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.89 Cr
as on 04-01-2025
- Revenue 519.69%
(FY 2020)
- Profit 2085.40%
(FY 2020)
- Ebitda -198.01%
(FY 2020)
- Net Worth 1006.04%
(FY 2020)
- Total Assets 1225.00%
(FY 2020)
About Medfin Pharma Services
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.89 Cr.
Kamalakar Meeripelly and Uma Meeripelly serve as directors at the Company.
- CIN/LLPIN
U24290TG2017PTC117634
- Company No.
117634
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jun 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Warangal, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Medfin Pharma Services?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamalakar Meeripelly  | Director | 07-Jun-2017 | Current |
| Uma Meeripelly | Director | 07-Jun-2017 | Current |
Financial Performance of Medfin Pharma Services.
Medfin Pharma Services Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 519.69% increase. The company also saw a substantial improvement in profitability, with a 2085.4% increase in profit. The company's net worth Soared by an impressive increase of 1006.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medfin Pharma Services?
In 2020, Medfin Pharma Services had a promoter holding of 87.25% and a public holding of 12.75%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Laava International Sports FoundationActive 6 years 10 monthsKamalakar Meeripelly and Uma Meeripelly are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Dec 2022 | ₹1.50 Cr | Open |
Others Creation Date: 20 Dec 2022 | ₹3.94 M | Open |
How Many Employees Work at Medfin Pharma Services?
Unlock and access historical data on people associated with Medfin Pharma Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medfin Pharma Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medfin Pharma Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
